Hybrid Mammarenavirus Variants Show Promise for Cross-Protective Vaccine Development
Researchers created computationally designed hybrid variants of Junin and Machupo virus receptor-binding proteins that can infect human cells while remaining recognizable to immune antibodies from infected patients. The study reveals how these pathogenic viruses balance the need to enter cells with evading immune detection. The findings could guide development of broadly protective antiviral therapies against these dangerous hemorrhagic fever viruses.
Scientists used computational methods to design hybrid variants combining genetic sequences from Junin virus (JUNV) and Machupo virus (MACV), two pathogenic mammarenaviruses that cause hemorrhagic fevers. These hybrid GP1 proteins maintained the ability to bind human transferrin receptor 1 (hTfR1) for cellular entry while remaining susceptible to neutralizing antibodies, including those from JUNV convalescent patients. Structural analysis using cryo-electron microscopy revealed how the hybrid variants achieve this dual functionality. When used as immunogens, these variants elicited cross-reactive neutralizing antibodies in animal models. The research suggests that viral sequence adaptation represents a balance between receptor recognition and immune evasion, providing a rational framework for designing broadly neutralizing antiviral therapies targeting these viruses.
Limitations & open questions
The study does not discuss potential limitations of the computational hybridization approach, such as whether designed variants might have reduced fitness in natural settings or whether cross-neutralizing responses would be durable in humans. The paper also does not address how these findings might translate to clinical vaccine candidates or timelines for further development.
What different sources said
- bioRxivCenter
Computationally hybridized pathogenic mammarenavirus receptor binding domains reveal cryptic variants that elicit cross-neutralizing immune responses
Related
Fluorescence Correlation Spectroscopy Used to Monitor Chlamydia Protein Production in Cell-Free System
Researchers used fluorescence correlation spectroscopy (FCS) to track the real-time production of a Chlamydia outer protein (CopB) fused with a fluorescent marker in a cell-free protein synthesis system. The technique allowed them to measure protein concentration, size, aggregation, and maturation rates without requiring protein purification. This approach could streamline the characterization of proteins during synthesis for research and biotechnology applications.
DNA Origami Nanoparticles with Oligolysine Coating Show Promise for Retinal Cell Uptake
Researchers found that coating DNA origami nanoparticles with PEG5K-K10, a cationic polymer, significantly improves their uptake into retinoblastoma cells while maintaining safety and mobility in the eye. The coating was essential for cell internalization and did not impair the particles' ability to diffuse through the vitreous humor. These findings suggest DNA origami nanoparticles could be viable carriers for delivering therapeutic agents to treat eye diseases.
Spatial Clustering of Adhesion-Deficient Cells Controls Epithelial Tissue Rigidity, Study Shows
A computational study using vertex modeling demonstrates that how adhesion-deficient cells are spatially arranged in epithelial tissue—not just their number—determines whether the tissue loses mechanical rigidity. Clustered mutant cells cause sustained mechanical changes through sequential boundary removal, while randomly distributed ones are rapidly eliminated with minimal lasting effects. The findings suggest spatial organization is a key factor in early-stage cancer progression and epithelial-mesenchymal transition.